HomeInsightsStock Comparison

Bharat Immunological Biological Corporation Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Bharat Immunological Biological Corporation Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Last Updated on: May 07, 2025

Key Highlights

  • The Latest Trading Price of Bharat Immunological & Biological Corporation Ltd is ₹ 22.18 as of 07 May 14:00.
  • The P/E Ratio of Bharat Immunological & Biological Corporation Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Torrent Pharmaceuticals Ltd changed from 32.6 on March 2020 to 53.2 on March 2024 . This represents a CAGR of 10.29% over 5 years.
  • The Market Cap of Bharat Immunological & Biological Corporation Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Torrent Pharmaceuticals Ltd changed from ₹ 33361 crore on March 2020 to ₹ 88030 crore on March 2024 . This represents a CAGR of 21.42% over 5 years.
  • The revenue of Bharat Immunological & Biological Corporation Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Torrent Pharmaceuticals Ltd for the Dec '24 is ₹ 2842 crore as compare to the Sep '24 revenue of ₹ 2873 crore. This represent the decline of -1.08%.
  • The ebitda of Bharat Immunological & Biological Corporation Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Torrent Pharmaceuticals Ltd for the Dec '24 is ₹ 947 crore as compare to the Sep '24 ebitda of ₹ 923 crore. This represent the growth of 2.6%.
  • The net profit of Bharat Immunological & Biological Corporation Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Torrent Pharmaceuticals Ltd changed from ₹ 378 crore to ₹ 503 crore over 7 quarters. This represents a CAGR of 17.73% .
  • The Dividend Payout of Bharat Immunological & Biological Corporation Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Torrent Pharmaceuticals Ltd changed from 57.71 % on March 2020 to 69.83 % on March 2024 . This represents a CAGR of 3.89% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Bharat Immunological & Biological Corporation Ltd

  • The Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science and Technology.
  • BIBCOL was incorporated in 1989.
  • The Company is engaged in the manufacture of Oral Polio Vaccine (OPV) , Zinc Tablets and Diarehha management Kit and BIB Sweet Tablets. The company's manufacturing unit is located in Bulandshahr Dist., Uttar Pradesh.
  • BIBCL installed a plant of 100 mln units.
  • Commercial production of the OPV started from Jan'96. The company has received firm orders for supply of OPV from the Ministry of Health and Family Welfare, Government of India, for use in the national immunisation programme.

About Torrent Pharmaceuticals Ltd

  • Torrent Pharmaceuticals Limited is a leading player in the Indian pharmaceutical sector, concentrating on the chronic and sub-chronic therapeutic segments.
  • The Company has established itself as a leader in developing niche pharmaceutical solutions through its patient-centric innovation.
  • The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Vitamins and Nutrients (VMN), Gastro-Intestinal (GI) and Anti-Diabetes (AD) therapies in India.
  • It has a strong international presence across more than 40 countries with operations in regulated and emerging markets, such as the US, Europe, Germany, Brazil and Rest of the World. The Company operates through its wholly-owned subsidiaries spread across 12 countries with major setups in the US, Germany and Brazil.

Bharat Immunological & Biological Corporation Ltd News Hub

News

Bharat Immunological & Biological Corporation Ltd leads losers in 'B' group

Relicab Cable Manufacturing Ltd, Precision Wires India Ltd, Brainbees Solutions Ltd and Fl...

Read more

08 Jan 2025 14:45

News

Bharat Immunological & Biological Corporation Ltd leads gainers in 'B' group

Bodhi Tree Multimedia Ltd, Mangal Credit & Fincorp Ltd, Innovana Thinklabs Ltd and Bartron...

Read more

06 Jan 2025 12:15

News

Bharat Immunological & Biolog.Corp. to hold board meeting

Bharat Immunological & Biolog.Corp. will hold a meeting of the Board of Directors of the C...

Read more

10 Aug 2024 17:28

News

Bharat Immunological & Biolog.Corp. announces board meeting date

Bharat Immunological & Biolog.Corp. will hold a meeting of the Board of Directors of the C...

Read more

01 Mar 2024 10:22

News

Bharat Immunological & Biolog.Corp. to convene AGM

Bharat Immunological & Biolog.Corp. announced that the 34th Annual General Meeting (AGM) o...

Read more

29 Nov 2023 10:47

News

Bharat Immunological & Biolog.Corp. to conduct AGM

Bharat Immunological & Biolog.Corp. announced that the 34th Annual General Meeting (AGM) o...

Read more

28 Nov 2023 18:37

Torrent Pharmaceuticals Ltd News Hub

News

Torrent Pharmaceuticals announces resignation of ED (Strategic Planning)

Torrent Pharmaceuticals announced that Pranav Mehta, Executive Director (Strategic Plannin...

Read more

27 Feb 2025 18:47

News

Torrent Pharmaceuticals Ltd rises for third consecutive session

Torrent Pharmaceuticals Ltd gained for a third straight session today. The stock is quotin...

Read more

07 Feb 2025 13:05

News

Torrent Pharmaceuticals Ltd slips for fifth straight session

Torrent Pharmaceuticals Ltd is down for a fifth straight session today. The stock is quoti...

Read more

04 Feb 2025 13:35

News

Torrent Pharma gains after Q3 PAT rises 14% YoY to Rs 503 cr

Revenue from operations grew 2.6% year on year (YoY) to Rs 2,762 crore in the quarter ende...

Read more

27 Jan 2025 14:33

News

Board of Torrent Pharmaceuticals recommends interim dividend

Torrent Pharmaceuticals announced that the Board of Directors of the Company at its meetin...

Read more

24 Jan 2025 17:25

News

Torrent Pharmaceuticals to declare Quarterly Result

Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 24...

Read more

15 Jan 2025 10:12

SWOT Analysis Of Torrent Pharmaceuticals Ltd

Strength

4

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Bharat Immunological & Biological Corporation Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Torrent Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Bharat Immunological & Biological Corporation Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Bharat Immunological & Biological Corporation Ltd and Torrent Pharmaceuticals Ltd

Which company has a larger market capitalization, Bharat Immunological & Biological Corporation Ltd or Torrent Pharmaceuticals Ltd?

Market cap of Bharat Immunological & Biological Corporation Ltd is 95 Cr while Market cap of Torrent Pharmaceuticals Ltd is 110,629 Cr

What are the key factors driving the stock performance of Bharat Immunological & Biological Corporation Ltd and Torrent Pharmaceuticals Ltd?

The stock performance of Bharat Immunological & Biological Corporation Ltd and Torrent Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bharat Immunological & Biological Corporation Ltd and Torrent Pharmaceuticals Ltd?

As of May 7, 2025, the Bharat Immunological & Biological Corporation Ltd stock price is INR ₹22.06. On the other hand, Torrent Pharmaceuticals Ltd stock price is INR ₹3268.9.

How do dividend payouts of Bharat Immunological & Biological Corporation Ltd and Torrent Pharmaceuticals Ltd compare?

To compare the dividend payouts of Bharat Immunological & Biological Corporation Ltd and Torrent Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions